-
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. Cell Rep. 2021 Jun 29; 35(13):109291.
Waters AM, Khatib TO, Papke B, Goodwin CM, Hobbs GA, Diehl JN, Yang R, Edwards AC, Walsh KH, Sulahian R, McFarland JM, Kapner KS, Gilbert TSK, Stalnecker CA, Javaid S, Barkovskaya A, Grover KR, Hibshman PS, Blake DR, Schaefer A, Nowak KM, Klomp JE, Hayes TK, Kassner M, Tang N, Tanaseichuk O, Chen K, Zhou Y, Kalkat M, Herring LE, Graves LM, Penn LZ, Yin HH, Aguirre AJ, Hahn WC, Cox AD, Der CJ. PMID: 34192548.
View in:
PubMed Mentions: Fields:
-
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Mol Oncol. 2021 Mar 24.
Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L. PMID: 33759347.
View in:
PubMed Mentions: Fields:
-
Proteoglycans as Mediators of Cancer Tissue Mechanics. Front Cell Dev Biol. 2020; 8:569377.
Barkovskaya A, Buffone A, Žídek M, Weaver VM. PMID: 33330449.
View in:
PubMed Mentions:
-
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. Sci Rep. 2020 10 12; 10(1):16992.
Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM. PMID: 33046784.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. Sci Rep. 2019 04 05; 9(1):5670.
Barkovskaya A, Seip K, Hilmarsdottir B, Maelandsmo GM, Moestue SA, Itkonen HM. PMID: 30952976.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCells
-
Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition. Cancer Lett. 2017 06 28; 396:117-129.
Halldorsson S, Rohatgi N, Magnusdottir M, Choudhary KS, Gudjonsson T, Knutsen E, Barkovskaya A, Hilmarsdottir B, Perander M, Mælandsmo GM, Gudmundsson S, Rolfsson Ó. PMID: 28323032.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCells
-
Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors. Oncotarget. 2016 Apr 12; 7(15):19997-20015.
Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L. PMID: 26918352.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimalsCells
-
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism. Oncotarget. 2016 Mar 15; 7(11):12464-76.
Itkonen HM, Gorad SS, Duveau DY, Martin SE, Barkovskaya A, Bathen TF, Moestue SA, Mills IG. PMID: 26824323.
View in:
PubMed Mentions:
24 Fields:
Translation:
HumansCells
-
Metabolic reprogramming supports the invasive phenotype in malignant melanoma. Cancer Lett. 2015 Sep 28; 366(1):71-83.
Bettum IJ, Gorad SS, Barkovskaya A, Pettersen S, Moestue SA, Vasiliauskaite K, Tenstad E, Øyjord T, Risa Ø, Nygaard V, Mælandsmo GM, Prasmickaite L. PMID: 26095603.
View in:
PubMed Mentions:
29 Fields:
Translation:
HumansCells